Sct. Hans Hospital, Denmark Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01119014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Research Institute for Biological Psychiatry, Sct. Hans Hospital, Denmark | Research Institute for Biological Psychiatry, Sct. Hans Hospital, Roskilde.

Active Ingredients

Drugs in Phase 4 Trials (2)

aripiprazole (abilify) (1 trial)

quetiapine (seroquel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mental Disorders (Phase 4)

Psychotic Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2